Cristina Ghenoiu

On Tuesday, Cowen and Company issued a company note on La Jolla Pharmaceutical Company (NASDAQ: LJPC) ahead of multiple drug trials for the company's pipeline. Currently, analysts at Cowen rate La Jolla Pharmaceutical as an Outperform with a $40 price target. Phil Nadeau and Cristina...